Zobrazeno 1 - 10
of 237
pro vyhledávání: '"E. Rivkin"'
Autor:
Sarah E. Rivkin
Publikováno v:
Chinese Medicine and Culture, Vol 6, Iss 2, Pp 194-204 (2023)
Recorded stories of the clinical encounter stretch back to ancient times. Throughout their history, these narratives have been called by different names, reflecting changes in format, function, and audience. This paper examines and explains the diffe
Externí odkaz:
https://doaj.org/article/f13af0a6a30d4aa499800908baf4682a
Autor:
Mehmet F. Fer, Chirag A. Shah, Erin D. Ellis, Heather L. Sloan, Erik Bailey, Gary E. Goodman, Tanya A. Wahl, Peter Jiang, Saul E. Rivkin, Charles W. Drescher, Dan Velijovich, Amy E. Bondurant, Henry G. Kaplan, Desiree Iriarte, James Moon
Publikováno v:
International Journal of Gynecologic Cancer. 29:325-333
ObjectiveOur goals were to: establish the maximum-tolerated dose of olaparib tablets combined with metronomic carboplatin and paclitaxel in patients with relapsed high-grade serous ovarian cancer; evaluate dose-limiting toxicities; and evaluate effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbacf5f9337c3066e219a50392843952
https://doi.org/10.1136/ijgc-2018-000035
https://doi.org/10.1136/ijgc-2018-000035
Autor:
Paul Frankel, Min S. Park, Paul Lin, Amy Hakim, Mark T. Wakabayashi, Mihaela C. Cristea, Benjamin Paz, Lucille Leong, Thanh H. Dellinger, Dean Lim, Timothy W. Synold, Saul E. Rivkin, Ernest S. Han, Joseph Chao, Robert J. Morgan, Vincent Chung, Mary Carroll, Neal Prakash
Publikováno v:
Cancer Chemother Pharmacol
PURPOSE: To evaluate intraperitoneal (IP) nab-paclitaxel in patients with advanced malignancies that are primarily confined to the peritoneal cavity in a phase I trial. METHODS: Using a 3+3 dose escalation of IP nab-paclitaxel on days 1, 8, and 15 of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3456f8f47cf80c6b1fa3830eff21f43
https://pubmed.ncbi.nlm.nih.gov/30623229
https://pubmed.ncbi.nlm.nih.gov/30623229
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Research. 70:P4-09
Background: Since 1990 the Swedish Cancer Institute Breast Cancer Research Registry has accrued over 10,900 cases with a 92% follow-up rate. We analyzed the incidence of recurrence over time to evaluate the appropriate duration of our long term follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7676a5683effc2632482461ee93a9512
https://doi.org/10.1158/0008-5472.sabcs10-p4-09-05
https://doi.org/10.1158/0008-5472.sabcs10-p4-09-05
Autor:
Bryan Goldman, Ralph Wong, Eileen M. O'Reilly, James L. Abbruzzese, Kendrith M. Rowland, Philip A. Philip, Cecilia M. Fenoglio-Preiser, Charles D. Blanke, Christopher L. Corless, Jacqueline Benedetti, Saul E. Rivkin, James N. Atkins, B. Mirtsching, Patrick J. Flynn, Alok A. Khorana
Publikováno v:
Journal of Clinical Oncology. 28:3605-3610
Purpose Patients with advanced pancreas cancer present with disease that is poorly responsive to conventional therapies. Preclinical and early clinical evidence has supported targeting the epidermal growth factor receptor (EGFR) signaling pathway in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be356552acc7358a41e5e13694e1562e
https://doi.org/10.1200/jco.2009.25.7550
https://doi.org/10.1200/jco.2009.25.7550
Autor:
Reuven Shavit, E. Rivkin
Publikováno v:
IEEE Antennas and Wireless Propagation Letters. 9:966-969
A new approach to design decoupling feeding networks for large antenna phased arrays is proposed. The approach is based on a combination of two existing methods, resulting in significant hardware savings. The decoupling network allows matching each o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d59120ab085d6ee0cce81fe30f569bb4
https://doi.org/10.1109/lawp.2010.2086425
https://doi.org/10.1109/lawp.2010.2086425
Autor:
Jane Arthur, Judith A. Malmgren, Saul E. Rivkin, Carolyn Y. Muller, James Moon, Heather Gerould, Desiree Iriarte
Publikováno v:
Clinical Ovarian Cancer. 2:112-117
Purpose Our objective was to find the maximum tolerated combination dose of daily oral lapatinib and weekly carboplatin (C) and paclitaxel (T; metronomic mCT). The secondary objectives included toxicity, safety, and efficacy of response to therapy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cec00e2522841ec1dbd53e6f998cb237
https://doi.org/10.3816/coc.2009.n.018
https://doi.org/10.3816/coc.2009.n.018
Autor:
Jackie Szymonifka, John Crowley, Antje Hoering, Bart Barlogie, Morie A. Gertz, Saul E. Rivkin, Madhav V. Dhodapkar
Publikováno v:
Blood. 113:793-796
The survival of patients with Waldenstrom macroglobulinemia (WM) varies enormously. The development of prognostic models in WM has been fraught by limited follow-up in current studies. Here, we update the outcome of a prospective WM trial with a medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c476ac936ca63f79bc1899cceeb39f
https://doi.org/10.1182/blood-2008-07-172080
https://doi.org/10.1182/blood-2008-07-172080
Autor:
Elisabeth J. Rushing, Cathryn Rankin, Robert B. Livingston, Deborah T. Blumenthal, Saul E. Rivkin, Alexander M. Spence, Mitchel S. Berger, Harmon J. Eyre, Allen Cohn, Keith J. Stelzer, Stephen H. Petersdorf
Publikováno v:
Cancer. 113:559-565
BACKGROUND. The poor prognosis reported for patients with high‒grade glial neoplasms indicates a need for the development of multimodality therapeutic approaches. The addition of chemotherapy has contributed variably to increased survival. The obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21ad9abc694c3ebb3753b39a55fbd34
https://doi.org/10.1002/cncr.23585
https://doi.org/10.1002/cncr.23585